English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/213475
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Green nanotechnology-based drug delivery systems for osteogenic disorders

AuthorsMedina Cruz, David; Mostafavi, Ebrahim; Vernet Crua, Ada; Cheng, Junjiang; Shah, Veer; Cholula-Díaz, Jorge L.; Guisbiers, Gregory; Tao, Juan; García-Martín, José Miguel ; Webster, Thomas J.
KeywordsGreen nanotechnology
Osteogenic disorders
Green nanotechnology
Drug delivery systems
Bone tissue regeneration
Controlled release
Targeted delivery
Bone disorders
Nano-engineered scaffolds
Issue Date17-Feb-2020
PublisherTaylor & Francis
CitationExpert Opinion on Drug Delivery 17(3): 341-356 (2020)
Abstract[Introduction] Current treatments for osteogenic disorders are often successful, however they are not free of drawbacks, such as toxicity or side effects. Nanotechnology offers a platform for drug delivery in the treatment of bone disorders, which can overcome such limitations. Nevertheless, traditional synthesis of nanomaterials presents environmental and health concerns due to its production of toxic by-products, the need for extreme and harsh raw materials, and their lack of biocompatibility over time.
[Areas covered] This review article contains an overview of the current status of treating osteogenic disorders employing green nanotechnological approaches, showing some of the latest advances in the application of green nanomaterials, as drug delivery carriers, for the effective treatment of osteogenic disorders.
[Expert opinion] Green nanotechnology, as a potential solution, is understood as the use of living organisms, biomolecules and environmentally friendly processes for the production of nanomaterials. Nanomaterials derived from bacterial cultures or biomolecules isolated from living organisms, such as carbohydrates, proteins, and nucleic acids, have been proven to be effective composites. These nanomaterials introduce enhancements in the treatment and prevention of osteogenic disorders, compared to physiochemically-synthesized nanostructures, specifically in terms of their improved cell attachment and proliferation, as well as their ability to prevent bacterial adhesion.
Publisher version (URL)https://doi.org/10.1080/17425247.2020.1727441
Appears in Collections:(IMN-CNM) Artículos
Files in This Item:
File Description SizeFormat 
Greeen nanotechnology-based.pdf1,85 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.